TBX2 expression is regulated by PAX3 in the melanocyte lineage

Pigment Cell and Melanoma Research

Volumn 26, Issue 1, 2013, Pages 67-77

  Liu, Fang ^a,b   Cao, Juxiang ^a   Lv, Jinghu ^c   Dong, Liang ^a,h   Pier, Eric ^a   Xu, George X ^d   Wang, Rui An ^e   Xu, Zhixiang ^f   Goding, Colin ^g   Cui, Rutao ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Rizhao General Hospital   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h SHANDONG UNIVERSITY   (China)

Author keywords

Melanocyte; Paired box homeotic gene 3; T box 2

Indexed keywords

T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR TBX2; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL LINEAGE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEM CELL;

ANIMALS; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAIRED BOX TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; T-BOX DOMAIN PROTEINS; UP-REGULATION;

EID: 84871403633     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12029     Document Type: Article

References (68)

1. Abrahams, A., Mowla, S., Parker, M.I., Goding, C.R., and Prince, S. (2008). UV-mediated regulation of the anti-senescence factor Tbx2. J. Biol. Chem. 283, 2223-2230.
2. Amthor, H., Huang, R., McKinnell, I., Christ, B., Kambadur, R., Sharma, M., and Patel, K. (2002). The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis. Dev. Biol. 251, 241-257.
3. Barr, F.G., Fitzgerald, J.C., Ginsberg, J.P., Vanella, M.L., Davis, R.J., and Bennicelli, J.L. (1999). Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59, 5443-5448.
4. Bertolotto, C., Busca, R., Abbe, P., Bille, K., Aberdam, E., Ortonne, J.P., and Ballotti, R. (1998). Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol. Cell. Biol. 18, 694-702.
5. Blake, J.A., and Ziman, M.R. (2005). Pax3 transcripts in melanoblast development. Dev. Growth Differ. 47, 627-635.
6. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M., and Goossens, M. (2000). Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907-1917.
7. Busca, R., and Ballotti, R. (2000). Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60-69.
8. Camp, R.L., Rimm, E.B., and Rimm, D.L. (1999). Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86, 2259-2265.
9. Carreira, S., Dexter, T.J., Yavuzer, U., Easty, D.J., and Goding, C.R. (1998). Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol. Cell. Biol. 18, 5099-5108.
10. Carreira, S., Liu, B., and Goding, C.R. (2000). The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J. Biol. Chem. 275, 21920-21927.
11. Carreira, S., Goodall, J., Aksan, I., La Rocca, S.A., Galibert, M.D., Denat, L., Larue, L., and Goding, C.R. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433, 764-769.
12. Conway, S.J., Bundy, J., Chen, J., Dickman, E., Rogers, R., and Will, B.M. (2000). Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H))/Pax3 mouse mutant. Cardiovasc. Res. 47, 314-328.
13. Cui, R., Nguyen, T.T., Taube, J.H., Stratton, S.A., Feuerman, M.H., and Barton, M.C. (2005). Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription. J. Biol. Chem. 280, 39152-39160.
14. Cui, R., Widlund, H.R., Feige, E., Lin, J.Y., Wilensky, D.L., Igras, V.E., D'Orazio, J., Fung, C.Y., Schanbacher, C.F., Granter, S.R., et al. (2007). Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128, 853-864.
15. Dong, L., Li, Y., Cao, J., Liu, F., Pier, E., Chen, J., Xu, Z., Chen, C., Wang, R.A., and Cui, R. (2012). FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription. Cell Death Differ. 19, 616-622.
16. Dorsky, R.I., Raible, D.W., and Moon, R.T. (2000). Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev. 14, 158-162.
17. Dunham, W.R., Klein, S.B., Rhodes, L.M., and Marcelo, C.L. (1996). Oleic acid and linoleic acid are the major determinants of changes in keratinocyte plasma membrane viscosity. J. Invest. Dermatol. 107, 332-335.
18. Epstein, D.J., Vogan, K.J., Trasler, D.G., and Gros, P. (1993). A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc. Natl Acad. Sci. USA 90, 532-536.
19. Fan, D., Liaw, A., Denkins, Y.M., Collins, J.H., Van Arsdall, M., Chang, J.L., Chakrabarty, S., Nguyen, D., Kruzel, E., and Fidler, I.J. (2002). Type-1 transforming growth factor-beta differentially modulates tumoricidal activity of murine peritoneal macrophages against metastatic variants of the B16 murine melanoma. J. Exp. Ther. Oncol. 2, 286-297.
20. Fenby, B.T., Fotaki, V., and Mason, J.O. (2008). Pax3 regulates Wnt1 expression via a conserved binding site in the 5′ proximal promoter. Biochim. Biophys. Acta 1779, 115-121.
21. Firnberg, N., and Neubuser, A. (2002). FGF signaling regulates expression of Tbx2, Erm, Pea3, and Pax3 in the early nasal region. Dev. Biol. 247, 237-250.
22. Galibert, M.D., Yavuzer, U., Dexter, T.J., and Goding, C.R. (1999). Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. J. Biol. Chem. 274, 26894-26900.
23. Gandini, S., Sera, F., Cattaruzza, M.S., Pasquini, P., Zanetti, R., Masini, C., Boyle, P., and Melchi, C.F. (2005). Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur. J. Cancer 41, 2040-2059.
24. Gao, L., Feng, Y., Bowers, R., Becker-Hapak, M., Gardner, J., Council, L., Linette, G., Zhao, H., and Cornelius, L.A. (2006). Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res. 66, 7880-7888.
25. Giuliano, S., Cheli, Y., Ohanna, M., Bonet, C., Beuret, L., Bille, K., Loubat, A., Hofman, V., Hofman, P., Ponzio, G., et al. (2010). Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res. 70, 3813-3822.
26. Goding, C.R. (2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712-1728.
27. Gupta, P.B., Kuperwasser, C., Brunet, J.P., Ramaswamy, S., Kuo, W.L., Gray, J.W., Naber, S.P., and Weinberg, R.A. (2005). The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 1047-1054.
28. Harris, R.G., White, E., Phillips, E.S., and Lillycrop, K.A. (2002). The expression of the developmentally regulated proto-oncogene Pax-3 is modulated by N-Myc. J. Biol. Chem. 277, 34815-34825.
29. Hoek, K.S., Schlegel, N.C., Eichhoff, O.M., Widmer, D.S., Praetorius, C., Einarsson, S.O., Valgeirsdottir, S., Bergsteinsdottir, K., Schepsky, A., Dummer, R., et al. (2008). Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res. 21, 665-676.
30. Hoogaars, W.M., Barnett, P., Rodriguez, M., Clout, D.E., Moorman, A.F., Goding, C.R., and Christoffels, V.M. (2008). TBX3 and its splice variant TBX3 + exon 2a are functionally similar. Pigment Cell Melanoma Res. 21, 379-387.
31. Horikawa, T., Norris, D.A., Zekman, T., and Morelli, J.G. (1996). Effective elimination of fibroblasts in cultures of melanocytes by lowering calcium concentration in TPA depleted medium following geneticin treatment. Pigment Cell Res. 9, 58-62.
32. Jacobs, J.J., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P.M., van Welsem, T., van de Vijver, M.J., Koh, E.Y., Daley, G.Q., et al. (2000). Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat. Genet. 26, 291-299.
33. Kingo, K., Philips, M.A., Aunin, E., Luuk, H., Karelson, M., Ratsep, R., Silm, H., Vasar, E., and Koks, S. (2006). MYG1, novel melanocyte related gene, has elevated expression in vitiligo. J. Dermatol. Sci. 44, 119-122.
34. Kubic, J.D., Young, K.P., Plummer, R.S., Ludvik, A.E., and Lang, D. (2008). Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res. 21, 627-645.
35. Lang, D., and Epstein, J.A. (2003). Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum. Mol. Genet. 12, 937-945.
36. Lang, D., Lu, M.M., Huang, L., Engleka, K.A., Zhang, M., Chu, E.Y., Lipner, S., Skoultchi, A., Millar, S.E., and Epstein, J.A. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884-887.
37. Martegani, E., Popolo, L., Alberghina, L., and Sturani, E. (1980). Reduction of ribosome activity and synthesis of stable RNA in Neurospora crassa. Biochim. Biophys. Acta 610, 318-330.
38. Mayanil, C.S., Pool, A., Nakazaki, H., Reddy, A.C., Mania-Farnell, B., Yun, B., George, D., McLone, D.G., and Bremer, E.G. (2006). Regulation of murine TGFbeta2 by Pax3 during early embryonic development. J. Biol. Chem. 281, 24544-24552.
39. McGill, G.G., Horstmann, M., Widlund, H.R., Du, J., Motyckova, G., Nishimura, E.K., Lin, Y.L., Ramaswamy, S., Avery, W., Ding, H.F., et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
40. Medic, S., and Ziman, M. (2009). PAX3 across the spectrum: from melanoblast to melanoma. Crit. Rev. Biochem. Mol. Biol. 44, 85-97.
41. Milewski, R.C., Chi, N.C., Li, J., Brown, C., Lu, M.M., and Epstein, J.A. (2004). Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 131, 829-837.
42. Moase, C.E., and Trasler, D.G. (1992). Splotch locus mouse mutants: models for neural tube defects and Waardenburg syndrome type I in humans. J. Med. Genet. 29, 145-151.
43. Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., et al. (2000). Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev. 25, 1245-1261.
44. Peres, J., Davis, E., Mowla, S., Bennett, D.C., Li, J.A., Wansleben, S., and Prince, S. (2010). The highly homologous t-box transcription factors, TBX2 and TBX3, have distinct roles in the oncogenic process. Genes Cancer 1, 272-282.
45. Philips, M.A., Vikesa, J., Luuk, H., Jonson, L., Lillevali, K., Rehfeld, J.F., Vasar, E., Koks, S., and Nielsen, F.C. (2009). Characterization of MYG1 gene and protein: subcellular distribution and function. Biol. Cell 101, 361-373.
46. Plummer, R.S., Shea, C.R., Nelson, M., Powell, S.K., Freeman, D.M., Dan, C.P., and Lang, D. (2008). PAX3 expression in primary melanomas and nevi. Mod. Pathol. 21, 525-530.
47. Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H., and Pavan, W.J. (2000). Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1-6.
48. Prince, S., Carreira, S., Vance, K.W., Abrahams, A., and Goding, C.R. (2004). Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res. 64, 1669-1674.
49. Pruitt, S.C., Bussman, A., Maslov, A.Y., Natoli, T.A., and Heinaman, R. (2004). Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo. Gene Expr. Patterns 4, 671-685.
50. Read, A.P., and Newton, V.E. (1997). Waardenburg syndrome. J. Med. Genet. 34, 656-665.
51. Rodriguez, M., Aladowicz, E., Lanfrancone, L., and Goding, C.R. (2008). Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res. 68, 7872-7881.
52. Sanchez-Martin, M., Perez-Losada, J., Rodriguez-Garcia, A., Gonzalez-Sanchez, B., Korf, B.R., Kuster, W., Moss, C., Spritz, R.A., and Sanchez-Garcia, I. (2003). Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am. J. Med. Genet. A 122A, 125-132.
53. Scholl, F.A., Kamarashev, J., Murmann, O.V., Geertsen, R., Dummer, R., and Schafer, B.W. (2001). PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61, 823-826.
54. Smit, D.J., Smith, A.G., Parsons, P.G., Muscat, G.E., and Sturm, R.A. (2000). Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur. J. Biochem. 267, 6413-6422.
55. Steingrimsson, E., Copeland, N.G., and Jenkins, N.A. (2005). Melanocyte stem cell maintenance and hair graying. Cell 121, 9-12.
56. Strub, T., Giuliano, S., Ye, T., Bonet, C., Keime, C., Kobi, D., Le Gras, S., Cormont, M., Ballotti, R., Bertolotto, C., et al. (2011). Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30, 2319-2332.
57. Tassabehji, M., Read, A.P., Newton, V.E., Harris, R., Balling, R., Gruss, P., and Strachan, T. (1992). Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635-636.
58. Tassabehji, M., Newton, V.E., Leverton, K., Turnbull, K., Seemanova, E., Kunze, J., Sperling, K., Strachan, T., and Read, A.P. (1994). PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Hum. Mol. Genet. 3, 1069-1074.
59. Vachtenheim, J., and Novotna, H. (1999). Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas. Cell. Mol. Biol. (Noisy-le-grand) 45, 1075-1082.
60. Vance, K.W., Carreira, S., Brosch, G., and Goding, C.R. (2005). Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65, 2260-2268.
61. Vance, K.W., Shaw, H.M., Rodriguez, M., Ott, S., and Goding, C.R. (2010). The retinoblastoma protein modulates Tbx2 functional specificity. Mol. Biol. Cell 21, 2770-2779.
62. Verastegui, C., Bille, K., Ortonne, J.P., and Ballotti, R. (2000). Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J. Biol. Chem. 275, 30757-30760.
63. Watanabe, A., Takeda, K., Ploplis, B., and Tachibana, M. (1998). Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat. Genet. 18, 283-286.
64. Yang, G., Li, Y., Nishimura, E.K., Xin, H., Zhou, A., Guo, Y., Dong, L., Denning, M.F., Nickoloff, B.J., and Cui, R. (2008). Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol. Cell 32, 554-563.
65. Yasumoto, K., Takeda, K., Saito, H., Watanabe, K., Takahashi, K., and Shibahara, S. (2002). Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J. 21, 2703-2714.
66. Yavuzer, U., and Goding, C.R. (1994). Melanocyte-specific gene expression: role of repression and identification of a melanocyte-specific factor, MSF. Mol. Cell. Biol. 14, 3494-3503.
67. Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G., and Goding, C.R. (1995). The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10, 123-134.
68. Zhu, B.K., and Pruitt, S.C. (2005). Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line. Melanoma Res. 15, 363-373.